Hidrasec

Hidrasec is a well-known medicinal product used primarily for the symptomatic treatment of acute diarrhea in adults. Its active ingredient, Racecadotril, was originally developed by the French pharmaceutical research company Bioprojet. The brand has been established as a global standard for stool-regulating medication, providing a more physiological approach than traditional motility inhibitors.

While the brand was originally a French innovation, its distribution and manufacturing rights are held by several major pharmaceutical entities depending on the region. In many European markets, including Austria as shown on the packaging, the product is distributed by Gebro Pharma, an independent pharmaceutical company based in Austria. However, the global manufacturing and ownership landscape for Hidrasec involves various multinational corporations, including Takeda and Abbott in different territories. The specific unit in the image is marketed by Gebro Pharma, a family-owned Austrian company that specializes in the production and distribution of high-quality medicinal products.